New York, June 11, 2024 (GLOBE NEWSWIRE) -- The Global reached in 2023 and is further anticipated to reach by 2033 according to Dimension Market Research. The market is anticipated to register a CAGR of from 2024 to 2033. Biopharma plastics provide many advantages, making them the ideal option for several healthcare uses.
Their low chemical reactivity, high resistivity, & good thermal stability make them the preferred materials for the production of products like containers, syringes, bioreactor bags & disposable connectors. PVC is set to dominate the global biopharma plastics market in 2024 due to its versatility, resistance, and ability to withstand various processes without cracking. Its higher usage in manufacturing disposable connectors, syringes, and filters is driven by exceptional resistance, flexibility, and tolerance to higher temperatures.
Moreover, biopharmaceutical plastic polymers gain popularity for providing durable, UV and chemical-resistant surfaces, alongside remarkable oxidation resistance, water repellency, and vapor permeability, ensuring the creation of robust, eco-friendly, and affordable products. In the biopharma plastics market, key players operate along with several regional medium and small companies. Major players continuously innovate polymers to meet the growing healthcare demand.
Further, intense competition rises globally, with major companies across various regions engaging in acquisitions, mergers, and collaborations to maintain their compe.
